Gene · 406924
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging functions and clinical applications of exosomal microRNAs in diseases. | Noncoding RNA Res | 2023 | 37250456 | PubTator, text mining | PubMed |
| Exosomes: Diagnostic and Therapeutic Implications in Cancer. | Pharmaceutics | 2023 | 37242707 | PubTator, text mining | PubMed |
| Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis. | Int J Mol Sci | 2023 | 37240338 | PubTator, text mining | PubMed |
| Study on the Mechanism for SIRT1 during the Process of Exercise Improving Depression. | Brain Sci | 2023 | 37239191 | PubTator, text mining | PubMed |
| Dynamic Role of Exosome microRNAs in Cancer Cell Signaling and Their Emerging Role as Noninvasive Biomarkers. | Biology (Basel) | 2023 | 37237523 | PubTator, text mining | PubMed |
| The influence of selected microRNAs on the expression profile of genes and proteins related to the tumor necrosis factor-alpha signaling pathways in endometrioid endometrial cancer. | J Cancer Res Clin Oncol | 2023 | 37233761 | PubTator, text mining | PubMed |
| Harnessing cancer stem cell-derived exosomes to improve cancer therapy. | J Exp Clin Cancer Res | 2023 | 37217932 | PubTator, text mining | PubMed |
| CTHRC1, a novel gene with multiple functions in physiology, disease and solid tumors (Review). | Oncol Lett | 2023 | 37216164 | PubTator, text mining | PubMed |
| Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. | Front Pharmacol | 2023 | 37205904 | PubTator, text mining | PubMed |
| Prediction of Early- and Late-Onset Pre-Eclampsia in the Preclinical Stage via Placenta-Specific Extracellular miRNA Profiling. | Int J Mol Sci | 2023 | 37175711 | PubTator, text mining | PubMed |
| Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes. | Int J Mol Sci | 2023 | 37175617 | PubTator, text mining | PubMed |
| Disturbed Oligodendroglial Maturation Causes Cognitive Dysfunction in Schizophrenia: A New Hypothesis. | Schizophr Bull | 2023 | 37163675 | PubTator, text mining | PubMed |
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| MNK Proteins as Therapeutic Targets in Leukemia. | Onco Targets Ther | 2023 | 37113687 | PubTator, text mining | PubMed |
| Small Extracellular Vesicles' miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases. | Pharmaceutics | 2023 | 37111701 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management. | Int J Mol Sci | 2023 | 37108371 | PubTator, text mining | PubMed |
| Astragaloside in cancer chemoprevention and therapy. | Chin Med J (Engl) | 2023 | 37075760 | PubTator, text mining | PubMed |
| Effect of Mir-4270 Inhibitor and Mimic on Viability and Stemness in Gastric Cancer Stem-Like Cells Derived from MKN-45 Cell Line. | Iran Biomed J | 2023 | 37070617 | PubTator, text mining | PubMed |
| Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis. | Transl Oncol | 2023 | 37062237 | PubTator, text mining | PubMed |
| miR-125b-5p, miR-155-3p, and miR-214-5p and Target E2F2 Gene in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 37047293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406924/papers?page=8